The Centers for Medicare and Medicaid Services did not explain why it was not finalizing the proposal, which the Biden ...

President Donald Trump’s team is rejecting former President Biden's plan to cover weight loss drugs like Wegovy and Zepbound ...

The Trump administration finalized new Medicare and Medicaid policies late Friday, but left out a key provision that would have expanded coverage for weight-loss drugs. In response, Eli Lilly stock ...

Health and Human Services Secretary Robert F. Kennedy Jr. has been a vocal critic of drugs like Ozempic which he said cloud ...

The Centers for Medicare & Medicaid Services will not cover drugs when exclusively used for weight loss, like Ozempic or Wegovy, the Trump administration announced.

President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the ...

The decision will not impact Medicare's existing coverage for drugs like Ozempic and Mounjaro, which can be used for weight ...

Administration officials reversed a decision made during the Biden presidency that would have given millions of people access ...

Health and Human Services Secretary Robert F. Kennedy Jr. has been critical of the drugs, instead placing a focus on ...

The Trump administration has chosen not to finalize a rule proposed by the Biden administration that would have allowed ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Trump officials reject Medicare coverage ...

The agency had previously drawn up plans to cut roughly 18% to 20% of the 100,000-person workforce by the middle of May.